Adverse drug reactions in neonates: could we be documenting more?



Hawcutt, Daniel B ORCID: 0000-0002-8120-6507, O'Connor, Olya and Turner, Mark A ORCID: 0000-0002-5299-8656
(2014) Adverse drug reactions in neonates: could we be documenting more? EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 7 (6). pp. 807-820.

[img] Text
Adverse Drug Reactions in Neonates Revised Final not tracked.docx - Unspecified
Access to this file is embargoed until Unspecified.

Download (421kB)

Abstract

Neonates are vulnerable to adverse drug reactions but reports of these events are relatively infrequent. Reporting can be increased by adapting a number of standard techniques to the unique features of neonatal care and pathology. However, clinicians and parents will be reluctant to report information about harms in the absence of mechanisms to ensure that reports affect clinical practice. Improved reporting will depend on education and cultural change that are informed by research about pharmacovigilance in neonatal settings. The efficient use of neonatal adverse drug reaction reports will require harmonization of terminology and interoperable databases.

Item Type: Article
Additional Information: alt_title: Adverse drug reactions in neonates: could we be documenting more?
Uncontrolled Keywords: adverse drug reaction, neonates, pharmacovigilance, spontaneous reporting scheme
Depositing User: Symplectic Admin
Date Deposited: 13 Jan 2016 10:43
Last Modified: 15 Dec 2022 12:06
DOI: 10.1586/17512433.2014.956090
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/2042305